On Tuesday, DaVita HealthCare DVA will release its latest earnings report. Here is Benzinga's outlook for the company.
Earnings and Revenue
Analysts expect DaVita HealthCare earnings of 94 cents per share. Revenue will likely be around $3.89 billion, according to the consensus estimate.
DaVita's EPS in the same period a year ago totaled 98 cents. Revenue was $3 billion. If the company were to match the consensus estimate when it reports Tuesday, earnings would be down 4.08 percent. Sales would be up 4.68 percent from the year-ago period.
DaVita HealthCare's reported EPS has stacked up against analyst estimates in the past like this:
Quarter | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 |
EPS Estimate | 0.94 | 0.9 | 0.82 | 0.91 |
EPS Actual | 0.81 | 0.92 | 0.79 | 0.98 |
Q4 EPS Estimate: 94 cents per share
Q4 Revenues Estimate: $3 billion
Stock Performance
Over the last 52-week period, shares are up 12.85 percent. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release.
Over the past 90 days, analysts have generally adjusted their estimates lower for EPS and revenues. The popular rating by analysts on DaVita stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.
Conference Call
DaVita's Q4 conference call is scheduled to begin at 5:00 p.m. ET and can be accessed here: https://edge.media-server.com/m6/p/geddoj92
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.